COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1336: Articles 13351-13360  | Next

Integrated miRNA/cytokine/chemokine profiling reveals immunopathological step changes associated with COVID-19 severity
WIlson, J. C., Kealy, D., James, S. R., Newling, K., Jagger, C., Filbey, K., Mann, E., Konkel, J., Menon, M., Knight, S. B., Simspon, A., CIRCO collaborative group, , Grainger, J. R., Hussell, T., Kaye, P. M., Signoret, N., Lagos, D.
10.1101/2021.08.04.21261471 — Posted: 2021-08-05
Negative impact of COVID-19 associated health system shutdown on patients diagnosed with colorectal cancer: a retrospective study from a large tertiary center in Ontario, Canada.
Forse, C. L., Petkiewicz, S., Teo, I., Purgina, B. M., Klaric, K.-A., Ramsay, T., Wasserman, J. K.
10.1101/2021.07.30.21261400 — Posted: 2021-08-05
SARS-CoV-2 antibody binding and neutralization in dried blood spot eluates and paired plasma
Itell, H. L., Weight, H., Fish, C. S., Logue, J. K., Franko, N., Wolf, C. R., McCulloch, D. J., Galloway, J., Matsen, F. A., Chu, H. Y., Overbaugh, J.
10.1101/2021.08.02.21261504 — Posted: 2021-08-04
An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
Perkins, G. D., Ji, C., Connolly, B. A., Couper, K., Lall, R., Baillie, J. K., Bradley, J. M., Dark, P., Dave, C., De Soyza, A., Dennis, A. V., Devrell, A., Fairbairn, S., Ghani, H., Gorman, E. A., Green, C. A., Hart, N., Hee, S. W., Kimbley, Z., Madathil, S., McGowan, N., Messer, B., Naisbitt, J., Norman, C., Parekh, D., Parkin, E. M., Patel, J., Regan, S. E., Ross, C., Rostron, A. J., Saim, M., Simonds, A. K., Skilton, E., Stallard, N., Steiner, M., Vancheeswaran, R., Yeung, J., McAuley, D. F., Recovery- RS collaborators
10.1101/2021.08.02.21261379 — Posted: 2021-08-04 Discussion: Onsite
Llamanade: an open-source computational pipeline for robust nanobody humanization
Sang, Z., Xiang, Y., Bahar, I., Shi, Y.
10.1101/2021.08.03.455003 — Posted: 2021-08-04
Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database
Zelenova, M., Ivanova, A., Semyonov, S., Gankin, Y.
10.1101/2021.08.04.454929 — Posted: 2021-08-04
Contribution of single mutations to selected SARS-CoV-2 emerging variants Spike antigenicity
Gong, S. Y., Chatterjee, D., Richard, J., Prevost, J., Tauzin, A., Gasser, R., Bo, Y., Vezina, D., Goyette, G., Gendron-Lepage, G., Medjahed, H., Roger, M., Cote, M., Finzi, A.
10.1101/2021.08.04.455140 — Posted: 2021-08-04
GlycoSHIELD: a versatile pipeline to assess glycan impact on protein structures
Gecht, M., von Bülow, S., Penet, C., Hummer, G., Hanus, C., Sikora, M.
10.1101/2021.08.04.455134 — Posted: 2021-08-04
Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity
Koide, A., Panchenko, T., Wang, C., Thannickal, S. A., Romero, L. A., Teng, K. W., Li, F.-Z., Akkapeddi, P., Corrado, A. D., Caro, J., Diefenbach, C., Samanovic, M. I., Mulligan, M. J., Hattori, T., Stapleford, K. A., Li, H. J., Koide, S.
10.1101/2021.08.03.454782 — Posted: 2021-08-04
A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
Wang, J. Y., Roehrl, M. W., Roehrl, V. B., Roehrl, M. H.
10.1101/2021.07.30.454526 — Posted: 2021-08-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).